Author:
Klomp Maria J.,van den Brink Lilian,van Koetsveld Peter M.,de Ridder Corrina M.A.,Stuurman Debra C.,Löwik Clemens W.G.M.,Hofland Leo J.,Dalm Simone U.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. International Union of Basic and Clinical Pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature;Günther;Pharmacol. Rev.,2018
2. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Pavel;Ann. Oncol.,2020
3. Management of carcinoid syndrome: a systematic review and meta-analysis;Hofland;Endocr. Relat. Cancer,2019
4. Peptide receptor radionuclide therapy with 177Lu-DOTATATE for symptomatic control of refractory carcinoid syndrome;Zandee;J. Clin. Endocrinol. Metab.,2021
5. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group;Rinke;J. Clin. Oncol.,2009